Inventor · Solana Beach, CA, US

Jan Elsner

22Patents
7h-index
64Co-inventors
68Inventor score

Filing activity: Sep 8, 2009 → Mar 29, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US8492381B2 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Chemistry; Metallurgy 41 Active
US8110578B2 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Chemistry; Metallurgy 39 Active
US9139534B2 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 25 Active
US8569494B2 Methods of synthesis and purification of heteroaryl compounds Chemistry; Metallurgy 19 Active
US9701643B2 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 18 Active
US8299056B2 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 18 Active
US8507492B2 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway Chemistry; Metallurgy 18 Active
US10040770B2 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 6 Active
US9346812B2 Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 5 Active
US9428509B2 Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 4 Active
US9771371B2 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Chemistry; Metallurgy 4 Active
US8907087B2 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Chemistry; Metallurgy 4 Active
US9079900B2 Methods of synthesis and purification of heteroaryl compounds Chemistry; Metallurgy 4 Active
US10266500B2 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 3 Active
US10919865B2 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 2 Active
US10167290B2 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Chemistry; Metallurgy 1 Active
US11325890B2 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 1 Active
US12129237B2 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 0 Active
US9795607B2 Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 0 Active
US11292796B2 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Chemistry; Metallurgy 0 Active
US10683298B2 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Chemistry; Metallurgy 0 Active
US9193692B2 Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.